Related Experiment Video

Updated: Mar 26, 2026

A Microscopic 2,3,5-Triphenyltetrazolium Chloride Assay for Accurate and Reliable Analysis of Myocardial Injury
11:17

A Microscopic 2,3,5-Triphenyltetrazolium Chloride Assay for Accurate and Reliable Analysis of Myocardial Injury

Published on: November 28, 2025

471

The challenges and impact of microvascular injury in ST-elevation myocardial infarction

Sebastian Johannes Reinstadler1,2,3, Thomas Stiermaier1,2, Georg Fuernau1,2

  • 1a University Heart Center Lübeck, Medical Clinic II, Department of Cardiology, Angiology and Intensive Care Medicine , University of Lübeck , Lübeck , Germany.

Expert Review of Cardiovascular Therapy
|January 23, 2016
PubMed

Insights

Microvascular injury (MVI) impairs blood flow in ST-elevation myocardial infarction patients despite restored epicardial flow. Current prevention and treatment strategies for MVI remain challenging and disappointing.

Area of Science:

  • Cardiology
  • Vascular Biology
  • Regenerative Medicine

Background:

  • ST-elevation myocardial infarction (STEMI) patients often experience microvascular injury (MVI) despite successful epicardial reperfusion.
  • MVI, also known as no-reflow phenomenon, is characterized by impaired microvascular perfusion.
  • MVI is linked to adverse clinical outcomes and poses a significant challenge in STEMI management.

Purpose of the Study:

  • To review the complex pathophysiology of microvascular injury (MVI) in STEMI.
  • To outline current diagnostic approaches for MVI.
  • To discuss the clinical consequences and explore existing prevention and treatment strategies for MVI.

Main Methods:

  • Literature review of pathophysiological mechanisms of MVI.
  • Analysis of diagnostic modalities for MVI detection.
  • Evaluation of clinical outcomes and treatment efficacy in MVI patients.

Main Results:

  • MVI pathophysiology is multifactorial, involving inflammation, endothelial dysfunction, and reperfusion injury.
  • Diagnostic tools include TIMI frame count, myocardial blush grade, and advanced imaging.
  • Despite its recognized impact, effective MVI prevention and treatment strategies are limited.

Conclusions:

  • Microvascular injury is a critical determinant of outcomes in STEMI patients.
  • Further research is needed to develop effective therapies for MVI.
  • Improved diagnostic and therapeutic approaches are essential for better STEMI patient care.

Keywords:
No-reflowST-elevation myocardial infarctionmicrovascular injurymicrovascular obstructionmyocardial infarctionpreventionprognosistreatment

More Related Videos

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis18:11

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

Published on: December 28, 2012

24.9K
Author Spotlight: Improved Localization and Monitoring of Coronary Flow Reserve Using Modified PLAX View in Mice05:07

Author Spotlight: Improved Localization and Monitoring of Coronary Flow Reserve Using Modified PLAX View in Mice

Published on: August 25, 2023

2.2K

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.6K
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
563
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
695
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.1K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
414